Thermostability of firefly luciferases affects efficiency of detection by in vivo bioluminescence

Molecular Imaging

Volumn 3, Issue 4, 2004, Pages 324-332

  Baggett, Brenda ^a   Roy, Rupali ^a   Momen, Shafinaz ^a   Morgan, Sherif ^a   Tisi, Laurence ^b   Morse, David ^a   Gillies, Robert J ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Breast cancer tumors; In vivo bioluminescence; Luciferase; Metastasis; Thermostability

Indexed keywords

BREAST CANCER TUMORS; IN VIVO BIOLUMINESCENCE; LUCIFERASE; METASTASIS;

ACTIVATION ENERGY; BIOLUMINESCENCE; BIOSYNTHESIS; ENTHALPY; ENZYME KINETICS; ENZYMES; GENES; MEDICAL IMAGING; MUTAGENESIS; ONCOLOGY; THERMAL EFFECTS; THERMODYNAMIC STABILITY; TUMORS;

GENETIC ENGINEERING;

FIREFLY LUCIFERASE; MESSENGER RNA; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; ENZYME STABILITY; GENETICS; HUMAN; IN VITRO STUDY; LUMINESCENCE; METABOLISM; MOUSE; MUTATION; PH; REPORTER GENE; TEMPERATURE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; ENZYME STABILITY; GENES, REPORTER; HUMANS; HYDROGEN-ION CONCENTRATION; LUCIFERASES, FIREFLY; LUMINESCENT MEASUREMENTS; MICE; MUTATION; RECOMBINANT PROTEINS; RNA, MESSENGER; TEMPERATURE;

EID: 13844281125     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.1162/1535350042973553     Document Type: Article

References (34)

1. Contag CH, Jenkins D, Contag PR, Negrin RS (2000). Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia. 2:41-52.
2. Contag CH, Spilman SD, Contag PR, Oshiro M, Eames B, Dennery P, Stevenson DK, Benaron DA (1997). Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol. 66:523-531.
3. Contag PR, Olomu IN, Stevenson DK, Contag CH (1998). Bioluminescent indicators in living mammals. Nat Med. 4: 245-247.
4. Rehemtulla A, Stegman LD, Cardozo SJ, Gupta S, Hall DE, Contag CH, Ross BD (2000). Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia. 2:491-495.
5. Wetterwald A, van der PG, Que I, Sijmons B, Buijs J, Karperien M, Lowik CW, Gautschi E, Thalmann GN, Cecchini MG (2002). Optical imaging of cancer metastasis to bone marrow: A mouse model of minimal residual disease. Am J Pathol. 160:1143-1153.
6. Shibata T, Giaccia AJ, Brown JM (2000). Development of a hypoxia-responsive vector for tumor-specific gene therapy. Gene Ther. 7:493-498.
7. Shibata T, Giaccia AJ, Brown JM (2002). Hypoxia-inducible regulation of a prodrug-activating enzyme for tumor-specific gene therapy. Neoplasia. 4:40-48.
8. Shin JH, Yi JK, Lee YJ, Kim AL, Park MA, Kim SH, Lee H, Kim CG (2003). Development of artificial chimerical gene regulatory elements specific for cancer gene therapy. Oncol Rep. 10: 2063-2069.
9. Chinnusamy V, Stevenson B, Lee BH, Zhu JK (2002). Screening for gene regulation mutants by bioluminescence imaging. Sci STKE. 2002:L10.
10. Rehemtulla A, Hall DE, Stegman LD, Prasad U, Chen G, Bhojani MS, Chenevert TL, Ross BD (2002). Molecular imaging of gene expression and efficacy following adenoviral-mediated brain tumor gene therapy. Mol Imaging. 1:43-55.
11. Chaudhuri TR, Rogers BE, Buchsbaum DJ, Mountz JM, Zinn KR (2001). A noninvasive reporter system to image adenoviral-mediated gene transfer to ovarian cancer xenografts. Gynecol Oncol. 83:432-438.
12. Brun S, Faucon-Biguet N, Mallet J (2003). Optimization of transgene expression at the posttranscriptional level in neural cells: Implications for gene therapy. Mol Ther. 7:782-789.
13. Siemens DR, Crist S, Austin JC, Tartaglia J, Ratliff TL (2003). Comparison of viral vectors: Gene transfer efficiency and tissue specificity in a bladder cancer model. J Urol. 170:979-984.
14. Nunn C, Feuerbach D, Lin X, Peter R, Hoyer D (2002). Pharmacological characterisation of the goldfish somatostatin sst5 receptor. Eur J Pharmacol. 436:173-186.
15. Kimm-Brinson KL, Moeller PD, Barbier M, Glasgow H, Jr, Burkholder JM, Ramsdell JS (2001). Identification of a P2X7 receptor in GH(4)C(1) rat pituitary cells: A potential target for a bioactive substance produced by Pfiesteria piscicida. Environ Health Perspect. 109:457-462.
16. Catania JM, Parrish AR, Kirkpatrick DS, Chitkara M, Bowden GT, Henderson CJ, Wolf CR, Clark AJ, Brendel K, Fisher RL, Gandolfi AJ (2003). Precision-cut tissue slices from transgenic mice as an in vitro toxicology system. Toxicol In Vitro. 17:201-205.
17. Billard P, DuBow MS (1998). Bioluminescence-based assays for detection and characterization of bacteria and chemicals in clinical laboratories. Clin Biochem. 31:1-14.
18. Bitton G, Koopman B (1992). Bacterial and enzymatic bioassays for toxicity testing in the environment. Rev Environ Contam Toxicol. 125:1-22.
19. Greer LF, Szalay AA, III (2002). Imaging of light emission from the expression of luciferases in living cells and organisms: A review. Luminescence. 17:43-74.
20. Hastings JW (1996). Chemistries and colors of bioluminescent reactions: A review. Gene. 173:5-11.
21. Viviani VR (2002). The origin, diversity, and structure func tion relationships of insect luciferases. Cell Mol Life Sci. 59: 1833-1850.
22. Lall AB, Ventura DS, Bechara EJ, de Souza JM, Colepicolo-Neto P, Viviani VR (2000). Spectral correspondence between visual spectral sensitivity and bioluminescence emission spectra in the click beetle Pyrophorus punctatissimus (Coleoptera: Elateridae). J Insect Physiol. 46:1137-1141.
23. Viviani VR, Silva AC, Perez GL, Santelli RV, Bechara EJ, Reinach FC (1999). Cloning and molecular characterization of the cDNA for the Brazilian larval click-beetle Pyrearinus termitilluminans luciferase. Photochem Photobiol. 70:254-260.
24. Schmitter RE, Njus D, Sulzman FM, Gooch VD, Hastings JW (1976). Dinoflagellate bioluminescence: A comparative study of in vitro components. J Cell Physiol. 87:123-134.
25. Day RN, Kawecki M, Berry D (1998). Dual-function reporter protein for analysis of gene expression in living cells. BioTechniques. 25:848-4, 856.
26. Leclerc GM, Boockfor FR, Faught WJ, Frawley LS (2000). Development of a destabilized firefly luciferase enzyme for measurement of gene expression. BioTechniques. 29:590-596, 598.
27. Souren JE, Wiegant FA, van Hof P, van Aken JM, van Wijk R (1999). The effect of temperature and protein synthesis on the renaturation of firefly luciferase in intact H9c2 cells. Cell Mol Life Sci. 55:1473-1481.
28. Souren JE, Wiegant FA, van Wijk R (1999). The role of hsp70 in protection and repair of luciferase activity in vivo; experimental data and mathematical modelling. Cell Mol Life Sci. 55: 799-811.
29. Herbst R, Schafer U, Seckler R (1997). Equilibrium intermediates in the reversible unfolding of firefly (Photinus pyralis) luciferase. J Biol Chem. 272:7099-7105.
30. Herbst R, Gast K, Seckler R (1998). Folding of firefly (Photinus pyralis) luciferase: Aggregation and reactivation of unfolding intermediates. Biochemistry. 37:6586-6597.
31. Baldwin TO, Chen LH, Chlumsky LJ, Devine JH, Ziegler MM (1989). Site-directed mutagenesis of bacterial luciferase: Analysis of the "essential" thiol. J Biolumin Chemilumin. 4:40-48.
32. Chen LH, Baldwin TO (1989). Random and site-directed mutagenesis of bacterial luciferase: Investigation of the aldehyde binding site. Biochemistry. 28:2684-2689.
33. Flynn GC, Beckers CJ, Baase WA, Dahlquist FW (1993). Individual subunits of bacterial luciferase are molten globules and interact with molecular chaperones. Proc Natl Acad Sci U.S.A. 90:10826-10830.
34. Thompson JF, Hayes LS, Lloyd DB (1991). Modulation of firefly luciferase stability and impact on studies of gene regulation. Gene. 103:171-177.